Real-World Outcomes in Fingolimod-Treated Patients with Multiple Sclerosis in the Czech Republic: Results from the 12-Month GOLEMS Study.

Tichá V, Kodým R, Počíková Z, Kadlecová P

Clin Drug Investig. 2017 Feb; 37(2):175-186. PMID: 27785735. Abstract